PDB13 A Cost of Control Analysis of Liraglutide Versus Other ANTI-Diabetic Therapies in the Treatment of Patient with Type 2 Diabetes in China
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.411
https://www.valueinhealthjournal.com/article/S1098-3015(21)00628-8/fulltext
Title :
PDB13 A Cost of Control Analysis of Liraglutide Versus Other ANTI-Diabetic Therapies in the Treatment of Patient with Type 2 Diabetes in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00628-8&doi=10.1016/j.jval.2021.04.411
First page :
Section Title :
Open access? :
No
Section Order :
10980